РецензированоEN2021

USE OF BETASERCA IN PATIENTS WITH HD WITH COCHLEOVESTIBULAR DISORDERS

U.S. Khasanov · N.A. Akhunjhanov (Researcher Tashkent Medical Academy, Uzbekistan) · G.S. Khaydarova (Researcher Tashkent Medical Academy, Uzbekistan) · K.E. Shaykhova (Researcher Tashkent Medical Academy, Uzbekistan) · U.P. Abdullaev (Researcher Tashkent Medical Academy, Uzbekistan)

International Journal of Medical Sciences And Clinical Research · 03 · 2021

Аннотация

Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear. It has a powerful stimulating effect by increasing the release of neurotransmitters (histamine) from the nerve endings of the inner ear receptor cells into the synapse. The neurotransmitter acts on the precapillary sphincters, causing vasodilation of the vessels of the inner ear, increasing their permeability and thereby normalizing intralabyrinthine pressure, i.e. eliminating hydrops. KEYWORDS Betahistine dihydrochloride, neuroreceptor cells, nerve. Volume 03 Issue 04-2023 62 International Journal of Medical Sciences And Clinical Research (ISSN – 2771-2265) VOLUME 03 ISSUE 04 PAGES: 62-67 SJIF IMPACT FACTOR (2021: 5. 694) (2022: 5. 893) (2023: 6. 184) OCLC – 1121105677 Publisher: Oscar Publishing Services Servi

Доказательный фрагмент

«Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear.»

Образец извлечения

Демо-превью

Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

doi.org/10.37547/ijmscr/Volume03Issue04-09